In this setting, electrocardiography, a fast and widely available method, still retains a significant role in everyday clinical assessment of this population. However, their availability is at present not universal, and interpretation requires a high level of expertise.
Novel modalities such as genetic testing and advanced imaging have allowed for substantial advancements in the understanding of this condition and facilitate patient management.
The comprehensive assessment of patients with hypertrophic cardiomyopathy is a complex process, with each step concurrently focusing on confirmation of the diagnosis, differentiation between sarcomeric and non-sarcomeric disease (phenocopy), and prognostication.
0 kommentar(er)
